Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator

ClinicalTrials.gov ID: NCT03198507

Public ClinicalTrials.gov record NCT03198507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind Active Comparator Controlled Phase III Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The "test and treat" strategy for treating dyspeptic patients who are H. pylori positive is rapidly becoming the standard of care. This study will test the effectiveness of RHB-105, a new triple therapy to treat H. pylori infection in dyspeptic patients against an active comparator.

Study identification

NCT ID
NCT03198507
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
RedHill Biopharma Limited
Industry
Enrollment
455 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2017 (Actual)
Primary completion
Oct 24, 2018 (Actual)
Completion
Dec 13, 2018 (Actual)
Last update posted
Mar 16, 2020

2017 – 2018

United States locations

U.S. sites
55
U.S. states
23
U.S. cities
49
Facility City State ZIP Site status
Research Site Dothan Alabama 36305 —
Research Site Phoenix Arizona 85018 —
Research Site Tucson Arizona 85710 —
Research Site North Little Rock Arkansas 72117 —
Research Site Anaheim California 92801 —
Research Site Chula Vista California 91910 —
Research Site Lomita California 90717 —
Research site San Carlos California 94070 —
Research Site Bristol Connecticut 06010 —
Research Site Aventura Florida 33180 —
Research Site Clearwater Florida 33765 —
Research Site Coral Springs Florida 33071 —
Research Site Homestead Florida 33030 —
Research Site Jacksonville Florida 28546 —
Research Site Lauderdale Lakes Florida 33319 —
Research Site Miami Florida 33144 —
Research Site Miami Florida 33165 —
Research Site Orange City Florida 32763 —
Research Site Palm Harbor Florida 34684 —
Research Site Athens Georgia 30607 —
Research Site Macon Georgia 31201 —
Research Site Marietta Georgia 30060 —
Research Site Elwood Indiana 46036 —
Research Site Metairie Louisiana 70006 —
Research Site Shreveport Louisiana 71105 —
Research Site Baltimore Maryland 21215 —
Research Site Chevy Chase Maryland 20815 —
Research Site Brockton Massachusetts 02302 —
Research Site Chesterfield Missouri 48047 —
Research Site Wyoming Missouri 49519 —
Research Site Las Vegas Nevada 89119 —
Research Site Las Vegas Nevada 89128 —
Research Site Great Neck New York 11023 —
Research Site Concord North Carolina 28025 —
Research Site Davidson North Carolina 28036 —
Research Site Fayetteville North Carolina 28304 —
Research Site Greenville North Carolina 27834 —
Research Site Tulsa Oklahoma 74135 —
Research Site Greenville South Carolina 29615 —
Research Site Sioux Falls South Dakota 57108 —
Research site Hermitage Tennessee 37076 —
Research Site Nashville Tennessee 37203 —
Research site Houston Texas 77043 —
Research Site Houston Texas 77079 —
Research Site Houston Texas 77084 —
Research Center Houston Texas 77090 —
Research site Houston Texas 77098 —
Research Site Longview Texas 75605 —
Research Site Richardson Texas 75082 —
Research Site San Antonio Texas 78229 —
Research Site Ogden Utah 84405 —
Research Site Charlottesville Virginia 22911 —
Research Site Christiansburg Virginia 24073 —
Research Site Lynchburg Virginia 24502 —
Research site Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03198507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03198507 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →